title: Ethanol Tolerance Affects Endogenous Adenosine Signaling in Mouse Hippocampus.
abstract: Ethanol has many pharmacological effects, including increases in endogenous adenosine levels and adenosine receptor activity in brain. Ethanol consumption is associated with both positive and negative health outcomes, but tolerance to the behavioral effects of ethanol can lead to increased consumption, which increases the risk of negative health outcomes. The present study was performed to test whether a 7-day treatment with ethanol is linked to reduced adenosine signaling and whether this is a consequence of reduced ecto-5'-nucleotidase activity. Wild-type (CD73(+/+)) and ecto-5'-nucleotidase-deficient (CD73(-/-)) mice were treated with ethanol (2 g/kg) or saline for 7 days. In CD73(+/+) mice, repeated ethanol treatment reduced the hypothermic and ataxic effects of acute ethanol, indicating the development of tolerance to the acute effects of ethanol. In CD73(+/+) mice, this 7-day ethanol treatment led to increased hippocampal synaptic activity and reduced adenosine A1 receptor activity under both basal and low Mg(2+) conditions. These effects of ethanol tolerance were associated with an 18% decrease in activity of ecto-5'-nucleotidase activity in hippocampal cell membranes. In contrast, ethanol treatment was not associated with changes in synaptic activity or adenosine signaling in hippocampus from CD73(-/-) mice. These data indicate that ethanol treatment is associated with a reduction in adenosine signaling through adenosine A1 receptors in hippocampus, mediated, at least in part, via reduced ecto-5'-nucleotidase activity.
authors.affiliation: Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.
authors.forename: Dali
authors.initials: D
authors.lastname: Zhang
authors.affiliation: Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.
authors.forename: Wei
authors.initials: W
authors.lastname: Xiong
authors.affiliation: Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Jackson
authors.affiliation: Department of Pharmacology and Therapeutics, University of Manitoba, and Neuroscience Research Program, Health Sciences Centre, Winnipeg, Manitoba, Canada Fiona.Parkinson@umanitoba.ca.
authors.forename: Fiona E
authors.identifier: 0000-0002-3196-2566
authors.initials: FE
authors.lastname: Parkinson
mesh_terms: D015720:5'-Nucleotidase / Q000235:genetics / Q000378:metabolism*; D000241:Adenosine / Q000378:metabolism*; D000818:Animals; D004361:Drug Tolerance; D000431:Ethanol / Q000097:blood / Q000494:pharmacology*; D006624:Hippocampus / Q000187:drug effects* / Q000201:enzymology / Q000378:metabolism; D008297:Male; D018345:Mice, Knockout; D043682:Receptor, Adenosine A1 / Q000235:genetics / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000187:drug effects*; D009435:Synaptic Transmission / Q000187:drug effects
chemical_list: D043682:Receptor, Adenosine A1; D000431:Ethanol; D015720:5'-Nucleotidase; D000241:Adenosine